{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:09:05Z","timestamp":1776920945380,"version":"3.51.2"},"reference-count":22,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Childhood obesity can affect drug disposition and efficacy of ibuprofen. The primary objective was to assess efficacy of ibuprofen in obese children.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>A systematic review was undertaken following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses methodology. Studies were identified from 12 databases. Two independent reviewers evaluated studies against the inclusion criteria and assessed for methodological quality.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>Any clinical setting.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients<\/jats:title><jats:p>Patients under 18 years who were overweight\/obese.<\/jats:p><\/jats:sec><jats:sec><jats:title>Interventions<\/jats:title><jats:p>Patients taking ibuprofen for any indication, dose or regimen.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main outcome measures<\/jats:title><jats:p>The efficacy and tolerability of ibuprofen treatment in obese children and presence of any adverse drug reactions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Searches identified 1305 studies. Four studies met inclusion criteria: three retrospective cohort studies (n=583, median age: 6 years, range: 1\u201318 years; n=200, median age: 11 years, range: 3\u201318 years; n=358 median age: 3.1 years, range: 1.2\u20138.5 years, respectively) and one case study. Each study differed in their method of dosing ibuprofen (weight-based, age-based and adjusted body weight dosing). Various doses were used: 5\u2009mg\/kg every 6\u2009hours, 400\u2009mg three times a day, 120\u2009mg\/dose and a dose calculated using adjusted body weight. One study reported efficacy (obese n=189, non-obese, n=394), where adequate pain control was achieved using 5\u2009mg\/kg. The other three studies did not determine if efficacy differed between obese and non-obese children.<\/jats:p><jats:p>One study described adverse effects. An increased risk of bleeding with ibuprofen was noted but did not differentiate between obese and non-obese children.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>There are little published data to guide clinicians prescribing ibuprofen in obese children.<\/jats:p><\/jats:sec><jats:sec><jats:title>PROSPERO registration number<\/jats:title><jats:p>CRD42021213500.<\/jats:p><\/jats:sec>","DOI":"10.1136\/archdischild-2022-324652","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T18:20:24Z","timestamp":1668622824000},"page":"67-71","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Ibuprofen efficacy, tolerability and safety in obese children: a systematic review"],"prefix":"10.1136","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2078-4733","authenticated-orcid":false,"given":"Eman","family":"Shamsaee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaw","family":"Huws","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8198-1028","authenticated-orcid":false,"given":"Andrea","family":"Gill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J","family":"McWilliam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8120-6507","authenticated-orcid":false,"given":"Daniel B","family":"Hawcutt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,11,16]]},"reference":[{"key":"2023051711051372000_108.1.67.1","unstructured":"Royal College of Paediatrics and Child Health . Childhood obesity position statement. Royal College of Paediatrics and Child Health, 2012: 6\u20139. https:\/\/www.rcpch.ac.uk\/sites\/default\/files\/page\/obesitypositionstatement.pdf"},{"key":"2023051711051372000_108.1.67.2","unstructured":"Department of Health . Childhood obesity: a plan for action [Internet]. Department of Health, 2017. Available: https:\/\/www.gov.uk\/government\/publications\/childhood-obesity-a-plan-for-action\/childhood-obesity-a-plan-for-action [Accessed 29 Nov 2017]."},{"key":"2023051711051372000_108.1.67.3","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2009.163055"},{"key":"2023051711051372000_108.1.67.4","first-page":"94","article-title":"Pharmacokinetics and drug dosing in obese children","volume":"15","author":"Kendrick","year":"2010","journal-title":"J Pediatr Pharmacol Ther"},{"key":"2023051711051372000_108.1.67.5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/23808993.2016.1138845","article-title":"Precision dosing in children","volume":"1","author":"Hawcutt","year":"2016","journal-title":"Expert Rev Precis Med Drug Dev"},{"key":"2023051711051372000_108.1.67.6","unstructured":"Medicines for Children . Ibuprofen for pain and inflammation [Internet]. Medicines for Children, 2008. Available: https:\/\/www.medicinesforchildren.org.uk\/ibuprofen-pain-and-inflammation [Accessed 21 Apr 2018]."},{"key":"2023051711051372000_108.1.67.7","unstructured":"National Institute for Health and Care Excellence . BNFc - Ibuprofen [Internet], 2020. Available: https:\/\/bnfc.nice.org.uk\/drug\/ibuprofen.html#sideEffects [Accessed 11 Jan 2020]."},{"key":"2023051711051372000_108.1.67.8","first-page":"654","article-title":"Caution on the use of NSAIDs in children : Recommendations by the Paediatric Working Group of AIFA (Italian Drug Agency)","volume":"29","author":"Baiardi","year":"2010","journal-title":"Medico e Bambino"},{"key":"2023051711051372000_108.1.67.9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10787-016-0302-3","article-title":"A clinical and safety review of paracetamol and ibuprofen in children","volume":"25","author":"Kanabar","year":"2017","journal-title":"Inflammopharmacology"},{"key":"2023051711051372000_108.1.67.10","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.chemosphere.2012.04.004","article-title":"Evaluation of aquatic plants for removing polar microcontaminants: a microcosm experiment","volume":"88","author":"Matamoros","year":"2012","journal-title":"Chemosphere"},{"key":"2023051711051372000_108.1.67.11","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-009-0016-x"},{"key":"2023051711051372000_108.1.67.12","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780281006"},{"key":"2023051711051372000_108.1.67.13","unstructured":"Critical Appraisal Skills Programme . CASP Checklists - CASP - Critical Appraisal Skills Programme [Internet], 2018. Available: https:\/\/casp-uk.net\/casp-tools-checklists\/ [Accessed 28 Mar 2019]."},{"key":"2023051711051372000_108.1.67.14","doi-asserted-by":"publisher","DOI":"10.1177\/0003489415583685"},{"key":"2023051711051372000_108.1.67.15","doi-asserted-by":"crossref","first-page":"e00398","DOI":"10.1002\/prp2.398","article-title":"Inconsistencies in dosage practice in children with overweight or obesity: a retrospective cohort study","volume":"6","author":"Gade","year":"2018","journal-title":"Pharmacol Res Perspect"},{"key":"2023051711051372000_108.1.67.16","doi-asserted-by":"crossref","first-page":"e386","DOI":"10.1097\/PCC.0000000000002072","article-title":"Antipyretic efficacy of acetaminophen and ibuprofen in critically ill pediatric patients","volume":"20","author":"Moffett","year":"2019","journal-title":"Pediatr Crit Care Med"},{"key":"2023051711051372000_108.1.67.17","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp140280"},{"key":"2023051711051372000_108.1.67.18","doi-asserted-by":"crossref","first-page":"e210775","DOI":"10.1001\/jamanetworkopen.2021.0775","article-title":"Association of ibuprofen prescription with acute kidney injury among hospitalized children in China","volume":"4","author":"Su","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2023051711051372000_108.1.67.19","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s00467-015-3105-7","article-title":"Ibuprofen-associated acute kidney injury in dehydrated children with acute gastroenteritis","volume":"30","author":"Balestracci","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"2023051711051372000_108.1.67.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2012.11.069"},{"key":"2023051711051372000_108.1.67.21","doi-asserted-by":"crossref","first-page":"e187896","DOI":"10.1001\/jamanetworkopen.2018.7896","article-title":"Association of nonsteroidal anti-inflammatory drug prescriptions with kidney disease among active young and middle-aged adults","volume":"2","author":"Nelson","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2023051711051372000_108.1.67.22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.seizure.2015.10.006","article-title":"Comparing paediatric intravenous phenytoin doses using physiologically based pharmacokinetic (PBPK) modelling software","volume":"33","author":"Batchelor","year":"2015","journal-title":"Seizure"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2022-324652","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T18:08:32Z","timestamp":1684346912000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2022-324652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,16]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12,15]]},"published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.1136\/archdischild-2022-324652"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2022-324652","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,16]]}}}